Confidence: 95%
B0CWVY3N64
View on Amazon →Decision summary
A middling option. It may be usable, but weaker dosing makes better alternatives worth comparing.
Best for
Buyers comparing price and availability and okay with a middle-of-the-pack option.
Consider another option if
You want one of the best-absorbed options in this category.
Score breakdown
Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.
Dosage quality
3.4/10Dosing looks weaker than ideal
Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).
Explore next
Creatine: high-bioavailability form declared (Creatine Monohydrate). The main limitation is that formula coherence is weak: diluted, decorative or overly complex.
Strengths
Weaknesses
Final verdict
A middling option. It may be usable, but weaker dosing makes better alternatives worth comparing.
A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.
ℹ Evidence is strong, but dose is below the optimal range
One of the weaker points: Dose is below the ranges usually used for stronger effects. The declared form supports strong absorption.
Scientific evidence
Avgerinos et al. meta-analysis creatine and cognitive function
Experimental Gerontology • 2018
PMID: 33578433.0
Brose et al. systematic review creatine and muscle strength
Medicine & Science in Sports & Exercise • 2003
PMID: 12945830.0
Evidence inferred from established knowledge, not directly linked studies
Solid but not a standout: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
✔ Clinically effective dose with strong supporting evidence
A clear drag on the formula: Dose is likely below clinically useful levels.
Scientific evidence
Wald et al. meta-analysis of folic acid and cardiovascular risk
BMJ • 2002
PMID: 15364185.0
Daly et al. RCT on folate supplementation and homocysteine reduction
New England Journal of Medicine • 1996
PMID: 9521168.0
⚠ Dose is below commonly used clinical ranges
A clear drag on the formula: Dose is likely below clinically useful levels.
Clinical dosing guidance
Based on established dosing ranges used in clinical practice.
Evidence inferred from established knowledge, not directly linked studies
Adequate, but not a key strength: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Important label or formulation details that may affect how this product should be interpreted.
Formula design looks less coherent than stronger alternatives
The formulation appears less focused than better-built options.
Folate dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Cranberry dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.
View methodology →This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.
See the best Creatine supplements ranked with the same methodology, or keep exploring the database.
